嘉德诺Cardinal Health（CAH）2023财年第三季度财报（英文版）（15页）.pdf

1、Exhibit 99.1 FOR IMMEDIATE RELEASE Cardinal Health Reports Third Quarter Fiscal Year 2023 Results and Raises Fiscal Year 2023 Non-GAAP EPS Guidance Revenue increased 13%to$50.5 billion GAAP1 operating earnings were$572 million;GAAP diluted EPS was$1.34 Non-GAAP operating earnings increased 11%to$606

2、 million;non-GAAP diluted EPS increased 20%to$1.74 Fiscal year 2023 non-GAAP EPS guidance raised and narrowed to$5.60 to$5.80,from$5.20 to$5.50 Fiscal year 2023 adjusted free cash flow guidance raised and narrowed to$2.0 to$2.3 billion,from$1.5 to$2.0 billion DUBLIN,Ohio,May 4,2023 Cardinal Health(N

3、YSE:CAH)today reported third quarter fiscal year 2023 revenues of$50.5 billion,an increase of 13%from the third quarter of fiscal year 2022.Third quarter GAAP operating earnings were$572 million and GAAP diluted earnings per share(EPS)were$1.34.Third quarter non-GAAP operating earnings increased 11%

4、to$606 million due to a significant increase in Pharmaceutical segment profit,partially offset by a decline in Medical segment profit.Non-GAAP diluted EPS increased 20%to$1.74,reflecting the improvement in non-GAAP operating earnings,a lower share count and lower interest expense,partially offset by

5、 a higher non-GAAP effective tax rate.Our third quarter results were led by continued momentum and growth in the Pharmaceutical segment,”said Jason Hollar,CEO of Cardinal Health.With the strong overall performance in the quarter,we are pleased to raise our full year non-GAAP EPS guidance by$0.35 at

6、the midpoint.In Medical,we continue to see improvement in underlying performance and remain confident in our Medical Improvement Plan initiatives.Across the enterprise,we continue to operate with urgency to drive our businesses forward and create value for our shareholders.Q3 FY23 summary Q3 FY23 Q3